Inovio Pharmaceuticals (INO)
(Delayed Data from NSDQ)
$12.00 USD
-0.79 (-6.18%)
Updated May 17, 2024 04:00 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -1.15 |
EPS Last Quarter | -1.31 |
Last EPS Surprise | -21.30% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.66 |
Next Year | -2.86 |
EPS (TTM) | -7.08 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.13M | 0.13M | 0.33M | 45.90M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 0.20M | 0.20M | 0.50M | 75.20M |
Low Estimate | 0.05M | 0.05M | 0.15M | 16.60M |
Year ago Sales | 0.23M | 0.39M | 0.83M | 0.33M |
Year over Year Growth Est. | -45.65% | -67.95% | -60.94% | 14,023.08% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.15 | -1.14 | -4.66 | -2.86 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -1.28 | -1.18 | -4.88 | -1.75 |
High Estimate | -0.94 | -1.00 | -4.09 | -1.75 |
Low Estimate | -1.28 | -1.24 | -5.02 | -4.03 |
Year ago EPS | -1.56 | -1.08 | -6.09 | -4.66 |
Year over Year Growth Est. | 26.28% | -5.56% | 23.48% | 38.63% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 2 | 2 | 2 | 1 |
Down Last 30 Days | 2 | 2 | 2 | 1 |
Down Last 60 Days | 2 | 2 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.15 | -1.14 | -4.66 | -2.86 |
7 Days Ago | -1.02 | -1.01 | -4.09 | -3.09 |
30 Days Ago | -1.02 | -1.01 | -4.09 | -3.09 |
60 Days Ago | -1.02 | -1.01 | -4.09 | -3.09 |
90 Days Ago | -0.86 | -0.83 | -3.80 | -2.56 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.15 | -1.14 | -4.66 | -2.86 |
Zacks Consensus Estimate | -1.15 | -1.14 | -4.66 | -2.86 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.31 | NA | -1.08 | -1.56 | NA |
Estimate | -1.08 | NA | -1.56 | -1.68 | NA |
Difference | -0.23 | NA | 0.48 | 0.12 | 0.12 |
Surprise | -21.30% | NA | 30.77% | 7.14% | 5.54% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more